|
YPEL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13469999454929E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07850000544241E-08 |
| Normal-vs-Stage2 |
1.96486999999301E-05 |
| Normal-vs-Stage3 |
1.3446000002304E-07 |
| Normal-vs-Stage4 |
2.373300E-04 |
| Stage1-vs-Stage2 |
5.403400E-01 |
| Stage1-vs-Stage3 |
9.074200E-01 |
| Stage1-vs-Stage4 |
9.098200E-01 |
| Stage2-vs-Stage3 |
6.553200E-01 |
| Stage2-vs-Stage4 |
6.274400E-01 |
| Stage3-vs-Stage4 |
8.580200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04599999772859E-08 |
| Normal-vs-AfricanAmerican |
4.25930000158559E-08 |
| Normal-vs-Asian |
1.343970E-02 |
| Caucasian-vs-AfricanAmerican |
8.570300E-02 |
| Caucasian-vs-Asian |
4.351000E-01 |
| AfricanAmerican-vs-Asian |
9.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.73239999912545E-09 |
| Normal-vs-Female |
3.48109999714907E-08 |
| Male-vs-Female |
7.022000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.18410001195934E-09 |
| Normal-vs-Extreme_Weight |
3.00129998631604E-09 |
| Normal-vs-Obese |
1.19169999979185E-07 |
| Normal-vs-Extreme_Obese |
2.16320000023806E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.564000E-01 |
| Normal_Weight-vs-Obese |
4.654000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.451400E-01 |
| Extreme_Weight-vs-Obese |
4.893500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.273800E-01 |
| Obese-vs-Extreme_Obese |
1.974600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.391700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.01010000030932E-07 |
| Normal-vs-Age(61-80Yrs) |
5.00719998797194E-09 |
| Normal-vs-Age(81-100Yrs) |
3.70149999999736E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.635000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.029820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.327800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.961800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.122200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.636400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.86219997597459E-09 |
| Normal-VS-Type2 PRCC |
1.53659995838495E-09 |
| Normal-VS-KIRP CIMP |
4.220900E-04 |
| Normal-VS-Unclassified PRCC |
2.61870000017872E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.662790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.023860E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.441580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.971960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.188000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.580590E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.37180300241857E-11 |
| Normal-vs-N1 |
3.19520000013895E-07 |
| Normal-vs-N2 |
1.599760E-02 |
| N0-vs-N1 |
2.302600E-01 |
| N0-vs-N2 |
7.536400E-01 |
| N1-vs-N2 |
7.851200E-01 |
|
|
